ALSO NOTED: Transgene looks for vaccine partner; Shortage of rabies vaccine develops; and much more...

Vaccine Research

France's Transgene says it plans to look for a partner to develop its investigational lung cancer vaccine after concluding a successful Phase IIb trial. Report

Generex Biotechnology presented final results of the Phase I trial of its AE37 immunotherapeutic vaccine in breast cancer patients at the recent ASCO meeting. Release

The FDA has approved a Phase I clinical trial for a potential diabetes vaccine. Story

BN ImmunoTherapeutics has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer. Release

Medicago announced positive results from a preclinical immunogenicity study of the company's H5N1 Avian Influenza VLP vaccine performed in ferrets. Release

Hemispherx Biopharma has completed enrollment in a Phase II clinical trial to evaluate the safety and efficacy of Ampligen as an enhancer for seasonal influenza vaccine. Report

Vaccines Market

Texas officials are advising added caution around wildlife, noting that there's a nationwide shortage of rabies vaccine. Report

Jim Carrey and Jenny McCarthy hope to leverage their celebrity status to warn parents that children receive too many vaccines at too early an age. McCarthy's son suffers from autism, which many parents have blamed on thimerosal. A multitude of studies, though, has concluded that there is no link. Story

Ireland is expected to launch a cervical cancer vaccination program. Report

Suggested Articles

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

Not wanting to be left behind in the COVID-19 vaccine race, Europe is stepping up its efforts secure supplies if any immunizations prove effective.

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.